Haemonetics Corporation and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of March 5, 2021 0.00% Convertible Senior Notes due 2026Indenture • March 5th, 2021 • Haemonetics Corp • Surgical & medical instruments & apparatus • New York
INDENTURE, dated as of March 5, 2021 between Haemonetics Corporation, a Massachusetts corporation, as issuer (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).
To: Haemonetics Corporation 125 Summer Street Boston, Massachusetts 02110 Attention: Telephone No.: Email:Letter Agreement • March 5th, 2021 • Haemonetics Corp • Surgical & medical instruments & apparatus
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [____] (“Dealer”) and Haemonetics Corporation (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
